FTI
63
2
GPS
63
4
HSY
45
-3
ADT
15
-5
CSX
43
-4
BF.B
53
3
NWSA
71
-4
AMG
43
3
BLK
64
17
SJM
36
2
SNA
55
3
COF
60
3
PBI
26
4
AAL
20
2
XYL
47
6
AVY
75
3
DG
32
6
DTE
43
10
NVDA
66
-2
LEN
55
2
FTI
63
2
GPS
63
4
HSY
45
-3
ADT
15
-5
CSX
43
-4
BF.B
53
3
NWSA
71
-4
AMG
43
3
BLK
64
17
SJM
36
2
SNA
55
3
COF
60
3
PBI
26
4
AAL
20
2
XYL
47
6
AVY
75
3
DG
32
6
DTE
43
10
NVDA
66
-2
LEN
55
2
Financhill
Back

Akero Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
67

AKRO
Akero Therapeutics

Last Price:
22.88
Seasonality Move:
13.01%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Buy
67
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $22.91. The Score for AKRO is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $22.91
    The current trend is moderately bullish and AKRO is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.87 Buy
Relative Strength Index (14 RSI): 57.68 Buy
Chaikin Money Flow: -38259 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.95 - 22.79) Buy
Bollinger Bands (100): (19.47 - 25.87) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.33 Sell
20-day SMA: 20.96 Buy
50-day SMA: 20.93 Buy
200-day SMA: 24.52 Sell
8-day EMA: 23.01 Sell
20-day EMA: 21.81 Buy
50-day EMA: 21.61 Buy
200-day EMA: 25.49 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.83 per share, and a decrease next year of $0.65 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):